SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-22-016148
Filing Date
2022-08-09
Accepted
2022-08-09 17:00:53
Documents
72
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q snse-20220630.htm   iXBRL 10-Q 2250636
2 EX-10.1 snse-ex10_1.htm EX-10.1 220855
3 EX-31.1 snse-ex31_1.htm EX-31.1 20180
4 EX-31.2 snse-ex31_2.htm EX-31.2 20501
5 EX-32.1 snse-ex32_1.htm EX-32.1 12502
  Complete submission text file 0000950170-22-016148.txt   8642890

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT snse-20220630_pre.xml EX-101.PRE 401335
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT snse-20220630.xsd EX-101.SCH 62799
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT snse-20220630_lab.xml EX-101.LAB 539918
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT snse-20220630_cal.xml EX-101.CAL 64832
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT snse-20220630_def.xml EX-101.DEF 244835
66 EXTRACTED XBRL INSTANCE DOCUMENT snse-20220630_htm.xml XML 1342729
Mailing Address 620 PROFESSIONAL DRIVE GAITHERSBURG MD 20879
Business Address 620 PROFESSIONAL DRIVE GAITHERSBURG MD 20879 (240) 243-8000
Sensei Biotherapeutics, Inc. (Filer) CIK: 0001829802 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39980 | Film No.: 221149246
SIC: 2834 Pharmaceutical Preparations